A program cochair said the agenda was designed to get attendees "out of their comfort zone." The annual meeting runs April 25 ...

The (AGA) is proud to announce the selection of 74 recipients to receive $2.4 million in research funding through the annual ...

More information on all MD Anderson AACR Annual Meeting content can be found at MDAnderson.org/AACR. Targeted small molecule ...

Mar. 3, 2025 — Researchers have shown how a low carbohydrate diet can worsen the DNA-damaging effects of some gut microbes to cause colorectal cancer. The study compared the effects of three ...

Cancer drugs' sexual toxicity warrants a "call to action" among oncologists to address the problem. ( Lancet Oncology) U.S.

Randale Scott, 35, who is also a pastor at Mayflower Baptist Church in Minden, has survived pancreatic and renal cancer, but now, cancer is attacking his other kidney too. Scott is scheduled for ...

Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

Pancreatic cancer is predicted to become the second-deadliest cancer in the US by 2030. Researchers at the Cold Spring Harbor Laboratory have found a way to slow the progression of pancreatic ...

In a recent video for Urology Times ®, Betty Wang, MD, provided insight on 3 presentations that she believes “may be game changing” in urology. The first study Wang highlighted was ...